Dabrafenib, 50 mg

Dabrafenib, 50 mg. A research-grade BRAF inhibitor used to study MAPK pathway biology in BRAF-mutant models. Provided as a solid powder suitable for preparing concentrated DMSO stocks.

• Manufacturer: STEMCELL Technologies; supplied by AFMS.
• Formulation: 50 mg powder.
• Handling: protect from light and moisture; store frozen (-20°C) or per label instructions.
• Use: for in vitro research only; not for human use.